Publicaciones en colaboración con investigadores/as de Cleveland Clinic (20)

2023

  1. Holistic Treatment Response: An International Expert Panel Definition and Criteria for a New Paradigm in the Assessment of Clinical Outcomes of Spinal Cord Stimulation

    Neuromodulation, Vol. 26, Núm. 5, pp. 1015-1022

  2. Impact of Long-Term Evoked Compound Action Potential Controlled Closed-Loop Spinal Cord Stimulation on Sleep Quality in Patients With Chronic Pain: An EVOKE Randomized Controlled Trial Study Subanalysis

    Neuromodulation, Vol. 26, Núm. 5, pp. 1030-1038

2022

  1. Pre-clinical validation of a turbine-based ventilator for invasive ventilation–The ACUTE-19 ventilator

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 69, Núm. 9, pp. 544-555

  2. Revascularization Strategies for Stable Left Main Coronary Artery Disease: Analysis of Current Evidence

    Journal of Cardiothoracic and Vascular Anesthesia, Vol. 36, Núm. 8, pp. 3370-3378

2021

  1. Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study

    npj Breast Cancer, Vol. 7, Núm. 1

2020

  1. A Systematic Literature Review of Peripheral Nerve Stimulation Therapies for the Treatment of Pain

    Pain Medicine (United States), Vol. 21, Núm. 8, pp. 1590-1603

  2. Correction: NSABP FB-7: A phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer (Breast Cancer Research (2019) 21 (133) DOI: 10.1186/s13058-019-1196-y)

    Breast Cancer Research

2019

  1. NSABP FB-7: A phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

    Breast Cancer Research, Vol. 21, Núm. 1

2018

  1. Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta-analysis

    Catheterization and Cardiovascular Interventions, Vol. 91, Núm. 2, pp. 330-342

  2. The 2017 European Society of Cardiology (ESC)/European Association of Cardiothoracic Surgeons (EACTS) Guidelines for Management of Valvular Heart Disease—Highlights and Perioperative Implications

    Journal of Cardiothoracic and Vascular Anesthesia, Vol. 32, Núm. 6, pp. 2810-2816

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

  2. Direct Xa inhibitors in addition to antiplatelet therapy in acute coronary syndrome: Meta-analysis of randomized trials

    Coronary Artery Disease, Vol. 28, Núm. 5, pp. 395-405

  3. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication

    Heart Rhythm, Vol. 14, Núm. 1, pp. e3-e40

  4. The Polyanalgesic Consensus Conference (PACC): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating Risks

    Neuromodulation, Vol. 20, Núm. 2, pp. 155-176

2016

  1. EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication

    Journal of Arrhythmia, Vol. 32, Núm. 4, pp. 247-278

  2. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication

    Europace, Vol. 18, Núm. 10, pp. 1455-1490

2014

  1. The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: The neuromodulation appropriateness consensus committee

    Neuromodulation, Vol. 17, Núm. 6, pp. 515-550

  2. The appropriate use of neurostimulation: Avoidance and treatment of complications of neurostimulation therapies for the treatment of chronic pain

    Neuromodulation, Vol. 17, Núm. 6, pp. 571-598

2013

  1. Treatment of idiopathic pulmonary fibrosis with Ambrisentan: A parallel, randomized trial

    Annals of Internal Medicine, Vol. 158, Núm. 9, pp. 641-649

2010

  1. Prediction of 30-day mortality in older patients with a first acute myocardial infarction

    Cardiology, Vol. 115, Núm. 1, pp. 1-9